guiding-goals

Pfizer boosts cancer drug roster with $14 billion Medivation deal

Medivation shares were up 20 percent at $80.43 in afternoon trading, just shy of the offer price of $81.50 per share. Shares of Pfizer, the largest U.S. drugmaker, were down 0.5 percent at $34.82. The offer is a 55-percent premium to Sanofi SA's initial offer to buy Medivation for $52.50 in April that pushed the San Francisco-based company to put itself up for sale.

Original post:
Pfizer boosts cancer drug roster with $14 billion Medivation deal

guiding-goals

U.S. clearance of ChemChina’s Syngenta deal removes key hurdle

Several U.S. lawmakers and groups representing farmers had expressed fears over a Chinese state-owned company being in a position to influence the U.S. food supply. Syngenta shares jumped as much as 12.5 percent on the news and ended trading on Monday up 10.6 percent at 421.20 Swiss francs ($437.9). ChemChina's $465 per share cash offer values the company at around 448 Swiss francs per share at current exchange rates, plus a special five-franc dividend

View post:
U.S. clearance of ChemChina’s Syngenta deal removes key hurdle

guiding-goals

Federal Reserve under growing pressure to reform system, goals

The U.S. Federal Reserve has two guiding goals when designing monetary policy: maximum employment and stable inflation. At this year's flagship economic policy conference, from Aug. 25 to 27, U.S policymakers will confer not only with their counterparts from around the world but also host…

Read the rest here: 
Federal Reserve under growing pressure to reform system, goals